retatrutide creator vs. Tirzepatide: What's The Difference? – Forbes Health 🎙️ NEW EPISODE: Retatrutide—The Triple
Description
Thought I'd share our background video to help explain insulin resistance
Overweight and obesity, National Heart, Lung, and Blood Institute (2022) Phentermine Hydrochloride prescribing information, FDA.gov Pharmacologic therapy for obesity, StatPearls (2024) Topiramate and phentermine, StatPearls (2023) Effects on weight reduction and safety of short-term phentermine administration in Korean obese people, Yonsei Medical Journal (2006) Clinical trial for evaluating the efficacy and safety of phentermine hydrochloride in obese patients, The Korean Journal of Obesity (2005) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

There was a survodutide dose-dependent decrease in bodyweight up to 8.7% with the high-dose survodutide producing greater bodyweight reduction compared to semaglutide [48]

This reduces gulping air (less belching and gas) and aids digestion
This means compounding pharmacies face restrictions on producing tirzepatide copies in most cases

Thankfully, there's a pretty simple definition
